ArticleTranslational pediatrics2025
Analysis of risk factors for retinopathy of prematurity: a single-center retrospective cohort study.
Article in Translational pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Retinopathy of prematurity (ROP) remains a significant cause of preventable childhood blindness worldwide. This study aimed to analyze perinatal and postnatal risk factors associated with ROP development in premature infants, with particular focus on potentially modifiable factors. Methods: This retrospective cohort study included 346 preterm infants who underwent ROP screening. Comprehensive data collection included demographic characteristics, maternal factors, clinical interventions, respiratory support parameters, and metabolic disorders. Variables with P<0.05 in bivariate analysis were included in multivariate logistic regression. Results: Among 346 preterm infants, 17 (4.91%) developed ROP. Multivariate analysis identified several significant independent risk factors for ROP development. Duration of non-invasive ventilation showed increased risk [odds ratio (OR) =1.49; 95% confidence interval (CI): 1.2-1.8; P=0.002], as did hypophosphatemia (OR =2.29; 95% CI: 1.2-3.5; P<0.001). Prolonged hospital stay (OR =1.35; 95% CI: 1.2-1.5; P=0.005) and apnea (OR =2.01; 95% CI: 1.2-2.1; P=0.03) were also significant risk factors. The ROP group demonstrated significantly higher rates of bronchopulmonary dysplasia (64.71% Conclusions: This study identified novel associations between metabolic derangements (particularly hypophosphatemia) and ROP development. The findings suggest that optimizing metabolic parameters, respiratory support, and nutritional management may offer new opportunities for ROP prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.